1. LBA-05Results from the large, open-label phase 3b CONSIGN study of regorafenib in patients with previously treated metastatic colorectal cancer. (30th June 2015) Authors: Van Cutsem, E.; Ciardiello, F.; Seitz, J-F.; Hofheinz, R.; Verma, U.; Garcia-Carbonero, R.; Grothey, A.; Miriyala, A.; Kalmus, J.; Shapiro, JA.; Falcone, A.; Zaniboni, A. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 4 Page Start: iv118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗